Alex Thompson

Stock Analyst at Stifel

(0.74)
# 2500
Out of 5,441 analysts
46
Total ratings
Success rate
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
ASND Ascendis Pharma
Maintains: Strong Buy
212 254
195.94 29.63% 3 Aug 8, 2025
CGEM Cullinan Therapeutic...
Reinstates: Buy
22
7.09 210.3% 1 Jun 11, 2025
KYMR Kymera Therapeutics
Reinstates: Buy
55
37.69 45.93% 1 May 20, 2025
TVTX Travere Therapeutics
Maintains: Hold
22 23
17.29 33.02% 3 May 2, 2025
THRD Third Harmonic Bio
Downgrades: Hold
23 5
5.38 -7.06% 2 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
8.92 303.59% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
27.39 119.06% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
49
n/a n/a 1 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 57
56.99 0.02% 4 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
485 500
638.76 -21.72% 4 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
36 54
15.22 254.8% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
44
18.93 132.44% 1 Feb 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
6 2
2.67 -25.09% 5 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 69
53.36 29.31% 2 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.64 -39.02% 4 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40
16.9 136.69% 2 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
9.45 3286.24% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
12.01 87.34% 1 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 34
14.76 130.35% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
43 41
40.39 1.51% 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
1.69 1852.66% 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
47.55 -22.19% 1 Sep 7, 2022